LUCAR-B68 cells Therapy(Nanjing Legend Biotech Co)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameLUCAR-B68 cells Therapy(Nanjing Legend Biotech Co)
Drug Alias NameLUCAR-B68 cellsLUCAR-B68 cells product
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionB-cell maturation protein modulators
TargetsB-cell maturation protein
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Legend Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Legend Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A